CD8A and neoplasm: Similarly, the IL-9/STAT3 signaling maintains the anti-tumor effect by upregulating FAO activity, decreasing intracellular LPO and resisting ferroptosis in CD8+ Tc9 (cytotoxic T lymphocyte subset 9) cells [165].